AG
CLLS

Aperio Group’s Cellectis CLLS Stock Holding History

Aperio Group’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$869K Sell
32,123
-3,375
-10% -$75.7K ﹤0.01% 1673
2020
Q3 		$657K Buy
35,498
+3,536
+11% +$62.7K ﹤0.01% 1662
2020
Q2 		$569K Sell
31,962
-12,911
-29% -$197K ﹤0.01% 1718
2020
Q1 		$413K Buy
44,873
+6,213
+16% +$92.7K ﹤0.01% 1746
2019
Q4 		$662K Buy
38,660
+23,371
+153% +$312K ﹤0.01% 1655
2019
Q3 		$159K Buy
15,289
+5,879
+62% +$79K ﹤0.01% 2199
2019
Q2 		$147K Buy
+9,410
New +$168K ﹤0.01% 2281
2018
Q2 		– Sell
-6,824
Closed -$215K – 2265
2018
Q1 		$215K Buy
+6,824
New +$216K ﹤0.01% 2111

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Aperio Group's CLLS Position: Q4 2020 in Review

Aperio Group reduced its Cellectis (CLLS) stake by 9.5% in Q4 2020, selling an estimated $75.7K and leaving 32,123 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #1673.

Aperio Group first reported a position in CLLS in Q1 2018 and has held it in 8 quarters since. 90 funds tracked by Wall St. Rank hold CLLS as of Q4 2020.

  • Aperio Group held 32,123 shares of Cellectis worth $869K as of Q4 2020.
  • Aperio Group sold 3,375 Cellectis shares in Q4 2020, an estimated $75.7K.
  • Cellectis made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1673 holding.
  • Aperio Group first reported a position in Cellectis in Q1 2018 and has held it in 8 quarters since.
  • 90 funds tracked by Wall St. Rank held Cellectis as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.